广达服务 PWR 深 沪
已收盘 08-01 16:00:00 美东时间
395.17
-10.960
-2.70%
华盛通- 最 高399.32
- 今 开392.60
- 成交量 209.41万股
- 最 低 384.57
- 昨 收 406.13
- 总市值 584.85亿
- 52周最高 424.94
- 市盈率 静 65.54
- 换手率 1.41%
- 52周最低 226.98
- 委 比 0.00%
- 总股本 1.48亿
- 历史最高 424.94
- 量 比 1.18
- 振 幅 3.63%
- 历史最低 13.51
- 每 手 1
- 风险率 43.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
08-01 01:21
Quanta Services Raises FY2025 Adj EPS Guidance from $10.05-$10.65 to $10.28-$10.88 vs $10.35 Est; Raises FY2025 Sales Guidance from $26.700B-$27.200B to $27.400B-$27.900B vs $27.013B Est
Quanta Services (NYSE:PWR) raises FY2025 Adj EPS guidance from $10.05-$10.65 to $10.28-$10.88 vs $10.35 analyst estimate. Raises FY2025 sales outlook from $26.700 billion-$27.200 billion to $27.400 billion-$27.900
07-31 18:56
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
美股大行评级 | 潜在涨幅36%！花旗上调Coinbase目标价升至505美元；摩根大通维持迪士尼"超配"评级，目标价升至138美元
今日重点评级关注：花旗：维持Apellis Pharmaceuticals"买入"评级，目标价从41美元升至46美元；杰富瑞：维持Kiniksa Pharmaceuticals"买入"评级，目标价从45美元升至54美元
07-30 09:36
Roth Capital Reiterates Buy on Quanta Services, Raises Price Target to $450
Roth Capital analyst Philip Shen reiterates Quanta Services (NYSE:PWR) with a Buy and raises the price target from $350 to $450.
07-30 01:03
美股大行评级 | 微软获上调目标价最高至570美元；摩根大通维持网易"超配"评级，目标价升至140美元
今日重点评级关注：Leerink Partners：维持Celcuity"跑赢大市"评级，目标价从28美元升至60美元；Macquarie：维持Churchill Downs"跑赢大市"评级，目标价从150美元升至155美元
07-29 09:30
UniSuper Ceases to be a Substantial Holder in Peter Warren Automotive
Peter Warren Automotive Holdings Ltd ( ($AU:PWR) ) has shared an update. UniSup...
07-28 14:28
Jupiter Neurosciences Highlights JOTROL;
JOTROL™ is currently advancing toward a Phase IIa trial in Parkinson's Disease, following breakthrough preclinical data in a well-established MPTP mouse model that demonstrated meaningful improvements in motor
07-23 20:14
